Invention Grant
- Patent Title: Multispecific antibodies against CD40 and CD137
-
Application No.: US17360438Application Date: 2021-06-28
-
Publication No.: US12077596B2Publication Date: 2024-09-03
- Inventor: Isil Altintas , David Satijn , Rik Rademaker , Paul Parren , Friederike Gieseke , Ugur Sahin
- Applicant: GENMAB A/S , BioNTech SE
- Applicant Address: DK Copenhagen V
- Assignee: GENMAB A/S,BioNTech SE
- Current Assignee: GENMAB A/S,BioNTech SE
- Current Assignee Address: DK Valby; DE Mainz
- Agency: LATHROP GPM LLP
- Agent James H. Velema, Esq.
- Priority: WO TEP2016066840 2016.07.14
- The original application number of the division: US16316534
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; G01N33/569
Abstract:
Multispecific antibodies binding to human CD40 and human CD137, methods for preparing such multispecific antibodies, and methods of using such multispecific antibodies for therapeutic or other purposes.
Public/Granted literature
- US20220033510A1 MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137 Public/Granted day:2022-02-03
Information query
